344 related articles for article (PubMed ID: 27199364)
1. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
2. Characterization of
Territo PR; Meyer JA; Peters JS; Riley AA; McCarthy BP; Gao M; Wang M; Green MA; Zheng QH; Hutchins GD
J Nucl Med; 2017 Mar; 58(3):458-465. PubMed ID: 27765863
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
4. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
6. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [
Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK
Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of P2X
Beaino W; Janssen B; Kooijman E; Vos R; Schuit RC; O'Brien-Brown J; Kassiou M; van Het Hof B; Vugts DJ; de Vries HE; Windhorst AD
J Neuroinflammation; 2020 Oct; 17(1):300. PubMed ID: 33054803
[TBL] [Abstract][Full Text] [Related]
8.
Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
[TBL] [Abstract][Full Text] [Related]
9. Increased uptake of the P2X7 receptor radiotracer
Morgan J; Moreno O; Alves M; Baz Z; Menéndez Méndez A; Leister H; Melia C; Smith J; Visekruna A; Nicke A; Bhattacharya A; Ceusters M; Henshall DC; Gómez-Vallejo V; Llop J; Engel T
Epilepsia; 2023 Feb; 64(2):511-523. PubMed ID: 36507708
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
Han J; Liu H; Liu C; Jin H; Perlmutter JS; Egan TM; Tu Z
Nucl Med Commun; 2017 May; 38(5):372-382. PubMed ID: 28338530
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
12. [
Van Weehaeghe D; Koole M; Schmidt ME; Deman S; Jacobs AH; Souche E; Serdons K; Sunaert S; Bormans G; Vandenberghe W; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2051-2064. PubMed ID: 31243495
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Novel P2X7 Receptor Radioligand [
Mikkelsen JD; Aripaka SS; Kaad S; Pazarlar BA; Pinborg L; Finsen B; Varrone A; Bang-Andersen B; Bastlund JF
ACS Chem Neurosci; 2023 Jan; 14(1):111-118. PubMed ID: 36535632
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging of P2X7 Receptor (P2X7R) for Neuroinflammation with Improved Radiosynthesis of Tracer
Huang G; Qiu Y; Bi L; Wei H; Li G; Li Z; Ye P; Yang M; Shen Y; Liu H; Wang L; Jin H
ACS Chem Neurosci; 2022 Dec; 13(23):3464-3476. PubMed ID: 36441909
[TBL] [Abstract][Full Text] [Related]
16. Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor Antagonist.
Xu Y; Miao X; Ravenstijn P; Hijzen A; Schmidt ME; Nandy P; Zhou H
Clin Transl Sci; 2020 Mar; 13(2):309-317. PubMed ID: 31642608
[TBL] [Abstract][Full Text] [Related]
17. Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [
Huang G; Lu X; Qiu Y; Bi L; Ye P; Yang M; Shen Y; Jin H; Han J
Bioorg Med Chem; 2022 Nov; 73():116996. PubMed ID: 36126443
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
19. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
